Eat Well Investment loses $1.3-million in Q1

• Eat Well Investment Group Inc. reported Q1 2026 financial results highlighting a 60% reduction in net loss to $1.3M, driven by a 49% increase in Adjusted EBITDA to $790K and expanded gross margins from 11.5% to 15.7%.
• Financing and transaction costs plummeted from $2.7M in Q1 2025 to just $8.3K, reflecting improved operational discipline and reduced reliance on costly debt restructuring.
• The company advanced its application to the BCSC and OSC to fully revoke its cease trade order (CTO), aiming to resume trading on the CSE. Continuous disclosure filings are now current for fiscal years 2023, 2024, and 2025.
• Cash position improved to $5.99M at quarter-end, up from $4.6M at year-end 2024.
• Management outlined priorities to refinance high-interest debt and grow high-margin segments, though the CTO revocation remains unguaranteed.

• The Q1 2026 results represent a Routine - Positive development. While operational metrics show genuine improvement, the news is a direct follow-up to the May 6, 2026 announcement regarding the filing of late financials and the CTO application.
• The market impact is currently neutralized by the suspended trading status. Until the CTO is fully revoked, the stock cannot trade, rendering short-term price action irrelevant.
• The reduction in financing costs and margin expansion are positive, but the company remains in a precarious financial position with a working capital deficit and explicit going concern warnings. The improvement is incremental and expected given the prior year's one-time refinancing fees.

• Eat Well Investment Group Inc. operates primarily through its wholly owned subsidiary, Belle Pulses Ltd.
• The flagship operation involves processing and selling pulse products, with facilities located in Saskatchewan, Canada, and Montana, U.S.
• The business model focuses on margin expansion through operational efficiency and cost management across its processing network.